Dave Roberts
@CDifficile1
Followers
436
Following
0
Media
47
Statuses
21K
Dave is a public health advocate who has spent 10 years studying C. Difficile. This account is updated daily and highlights media and journal sources.
Joined June 2011
Preoperative Oral Antibiotics Preparation is Associated With Improved 30-day Outcomes in Elective Colectomy for Ulcerative Colitis | Request PDF
researchgate.net
Request PDF | Preoperative Oral Antibiotics Preparation is Associated With Improved 30-day Outcomes in Elective Colectomy for Ulcerative Colitis | Background Ulcerative colitis (UC) is characterized...
0
0
0
Elevated Prevalence Of Digestive Disorders Drives Growth In The Clostridium Difficile-Associated Diarrhea Treatment Market: Key Driver Transforming the Difficile-Associated Diarrhea Treatment Market in 2025
0
0
2
Acurx Pharmaceuticals Advances To Phase 3 Trials For C. Difficile Infection, Stock Down - ProInvestor
proinvestor.com
(RTTNews) - Acurx Pharmaceuticals, Inc. (ACXP) Monday announced that its lead antibiotic candidate, ibezapolstat, is advancing to international Phase 3 clinical trials for treating C. difficile...
0
0
0
Virus vs. Bacteria: Phages Prove Effective at Killing Pathogens in Milk - UConn Today
today.uconn.edu
Food microbiologist Dennis D’Amico demonstrated that bacteriophages can effectively reduce the amount of common foodborne pathogens in milk
0
0
0
Clostridioides (Clostridium) difficile infection in hospitalized adult patients in Cambodia | Request PDF
researchgate.net
PDF | Despite high levels of global concern, little is known about the epidemiology of Clostridioides (Clostridium) difficile infection (CDI) in... | Find, read and cite all the research you need on...
0
0
0
Microbiota Transplant Shows Promise for Colon Infections - News Center
news.feinberg.northwestern.edu
Microbiota transplantation is safe and effective for treating clostridioides difficile infections, according to a clinical trial published in the journal Gastroenterology.
0
0
0
A Microbe from Poo Suppresses Bacterial Infection | The Scientist
the-scientist.com
A group of gut bacteria successfully hindered recurrent Clostridium difficile infection in mice, offering alternative therapeutic strategies to antibiotics and fecal transplant.
0
0
0
Synthetic microbiome therapy suppresses bacterial infection without antibiotics | Penn State University
psu.edu
A synthetic microbiome therapy, tested in mice, holds promise as a new treatment for C. difficile, a notoriously difficult-to-treat bacterial infection, according to a team of researchers at Penn...
0
0
1
Model-based cost-impact analysis of a diagnostic test for patients with community-acquired pneumonia in Canada | BMC Infectious Diseases | Full Text
link.springer.com
BMC Infectious Diseases - Antibiotics are broadly prescribed for community-acquired pneumonia (CAP) despite being only effective for bacterial infections. LIAISON® MeMed BV® (LMMBV) is a...
0
0
0
Fecal microbiota transplantation in a patient hospitalized in the intensive care unit – case report. - ScienceDirect
0
1
2
Primary Catalyst Driving Zinplava Market Evolution in 2025:
openpr.com
What Are the Projected Growth and Market Size Trends for the Zinplava Market In recent times the zinplava market has seen a XX CAGR expansion Predicted growth indicates an increase from XX million in...
0
0
0
Clinical and economic outcomes associated with fidaxomicin in comparison to vancomycin, metronidazole, and FMT: A systematic literature review - PubMed
pubmed.ncbi.nlm.nih.gov
Fidaxomicin was clinically effective compared to vancomycin. Fidaxomicin is often reported as cost-effective, consistently within high-risk subpopulations.
0
0
0
Clostridioides (Clostridium) difficile infection in hospitalized adult patients in Cambodia - PubMed
pubmed.ncbi.nlm.nih.gov
Clostridioides difficile is a significant cause of diarrhea worldwide, initially as a hospital-acquired infection and, more recently, as a community-associated infection. Risk factors for hospital-...
0
0
0
Clinical Characteristics and Outcomes of Clostridioides difficile Infection in Cancer Patients From a Tertiary Care Hospital - PubMed
pubmed.ncbi.nlm.nih.gov
Objective The objective of this study is to investigate the predisposing factors, disease course, potential complications, role of primary prophylaxis, and overall clinical outcomes of Clostridioides...
0
0
1
Higher disease activity of inflammatory bowel disease predisposes to Clostridioides difficile infection - PubMed
pubmed.ncbi.nlm.nih.gov
The major risk factors associated with CDI in IBD patients were IBD activity before infection, UC and colonic Crohn's disease, short duration of IBD, corticosteroid usage, and hospitalization....
0
1
0
Fecal microbiota transplantation for Clostridioides difficile infection in a peritoneal dialysis patient: A case report - PubMed
pubmed.ncbi.nlm.nih.gov
Chronic kidney disease (CKD) may be associated with dysbiosis which may increase the risk of gastrointestinal infections. Patients with kidney failure have a predominance of bacteria responsible for...
0
0
1
Enhanced immunogenicity of a Clostridioides difficile TcdB vaccine adjuvanted with a synthetic dual-TLR ligand adjuvant - PubMed
pubmed.ncbi.nlm.nih.gov
We report a comprehensive evaluation of the toxin B (TcdB) vaccine adjuvanted with a dual Toll-like receptor ligand liposome adjuvant for Clostridioides difficile infection (CDI). The vaccine...
0
0
1
Identification of two glycosyltransferases required for synthesis of membrane glycolipids in Clostridioides difficile - PubMed
pubmed.ncbi.nlm.nih.gov
Clostridioides difficile infections are the leading cause of healthcare-associated diarrhea. C. difficile poses a risk to public health due to its ability to form spores and cause recurrent infecti...
0
0
1
Predicting positive Clostridioides difficile test results using large-scale longitudinal data of demographics and medication history - PubMed
pubmed.ncbi.nlm.nih.gov
The models achieve high discrimination performance (AUROC >0.83). There is a general consensus among different analysis approaches regarding predictors that impact patients' chances of having a...
0
0
1
Burden of bacterial antimicrobial resistance among hospitalised patients in Spain: findings from three nationwide prospective studies - PubMed
pubmed.ncbi.nlm.nih.gov
The management costs of this study were funded by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). Researchers have participated voluntarily and none of the investigators...
0
0
0